Bloomage Capital Expenditures from 2010 to 2025

688363 Stock   48.35  1.05  2.13%   
Bloomage Biotechnology's Capital Expenditures is increasing over the years with slightly volatile fluctuation. Overall, Capital Expenditures is expected to go to about 1.2 B this year. From 2010 to 2025 Bloomage Biotechnology Capital Expenditures quarterly data regression line had arithmetic mean of  399,205,921 and r-squared of  0.85. View All Fundamentals
 
Capital Expenditures  
First Reported
2018-06-30
Previous Quarter
229 M
Current Value
126.9 M
Quarterly Volatility
89.5 M
 
Covid
Check Bloomage Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bloomage Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 13 M, Other Operating Expenses of 6.3 B or Net Income Applicable To Common Shares of 562.4 M, as well as many indicators such as . Bloomage financial statements analysis is a perfect complement when working with Bloomage Biotechnology Valuation or Volatility modules.
  
This module can also supplement various Bloomage Biotechnology Technical models . Check out the analysis of Bloomage Biotechnology Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Bloomage Stock

Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.